Nanoform Finland
1.292
EUR
+2.7 %
NANOFH
First North Finland
Medical Equipment & Services
Health Care
3,482 following
+2.7%
+14.54%
-20.74%
-28.3%
-18.49%
-18.74%
-79.75%
-
-74.42%
Nanoform Finland is a medical technology company. The company specializes in the research and development of technical products used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. The customers consist of companies in the global pharmaceutical industry. Nanoform Finland mainly operates in the Nordic market and is headquartered in Helsinki.
Read moreMarket cap
110.51M EUR
Turnover
105.67K EUR
Revenue
2.57M
EBIT %
-874.71 %
P/E
-
Dividend yield-%
-
Financial calendar
27/2
2025
Annual report '24
15/4
2025
General meeting '24
20/5
2025
Interim report Q1'25
ShowingAll content types
Nanoform Finland Plc - Manager's Transactions - Peter Hänninen
Nanoform Finland Plc - Manager's Transactions - Edward Hæggström
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools